Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Lumbar Spinal Fusion
NCT04272606Phase 2Completed
- Start
- Aug 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in degenerative disc disease (DDD) comparing Tranexamic Acid Arm with Placebo Arm (2 arms). Primary endpoints: Transfusion at 5 days, Blood Loss at 5 days and 1 more. Started Aug 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT04272606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04272606.